Trametinib for the Treatment of IGHV4–34, MAP2K1 Mutant Variant Hairy Cell Leukemia

類似資料

• Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenib
  著者:: Shenoi, Daniel P., 等
  出版事項: (2019)
• Co-Treatment of Hairy Cell Leukemia and Melanoma with the BRAF Inhibitor Dabrafenib
  著者:: Blachly, James S., 等
  出版事項: (2015)
• Phase 2 study of ibrutinib in classic and variant hairy cell leukemia
  著者:: Rogers, Kerry A., 等
  出版事項: (2021)
• Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective
  著者:: Andritsos, Leslie A., 等
  出版事項: (2015)
• Both variant and IGHV4-34–expressing hairy cell leukemia lack the BRAF V600E mutation
  著者:: Xi, Liqiang, 等
  出版事項: (2012)